Patent · US Active

Anti-FAM19A5 antibodies and uses thereof

US11618783B2 · kind B2 · utility

4Cited by
35References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 27, 2018
Grant dateApr 4, 2023
Priority date
Expiry dateAug 26, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/7158
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present disclosure provides antibodies that specifically bind to human FAM19A5 and compositions comprising such antibodies. Also provided herein are methods for treating fibrosis or cancer using the anti-FAM19A5 antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.